The Benchmark Company has recently reduced AbCellera Biologics Inc (ABCL) stock to Hold rating, as announced on August 20, 2024, according to Finviz. Earlier, on February 22, 2024 ...

As the U.S. stock market continues to rally following President Trump's return to office, investors are closely watching the impact of new policies on various sectors. In this context, penny ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cigna (CI – Research Report), Quest Diagnostics (DGX – ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Here's how you might feel the pinch from tariffs on Canadian good and services as they take effect this weekend.

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

After hours: 7:49:08 p.m. EST Loading Chart for ABCL ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Exxon Mobil CEO Darren Woods Says Yellowtail Project In Guyana Could Start By Q3 2025; Says Major Planned Projects For 2025 Could Begin Ahead Of Schedule Guidance is a report released by a public ...

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...